Timo Minssen

Professor

JUR Center for Advanced Studies in Bioscience Innovation Law
Karen Blixens Plads 16
2300 København S
- timo.minssen@jur.ku.dk
- https://jura.ku.dk/cebil/staff/profile/?pure=en/persons/381631
Mobil: +46708607517

ORCID: 0000-0002-3286-4888

Alle

361 - 370 ud af 413Pr. side: 10

Sortering: Titel

The Future Of AMR Policy Expert Workshop
Minssen, Timo (Deltager)
24 apr. 2023
Aktivitet: Deltagelse i arrangement eller begivenhed - typer › Deltagelse i workshop, seminar og kursus
The INAMRSS/CeBIL Copenhagen AMR Workshop: Solutions to AMR from the Social Sciences
Minssen, Timo (Arrangør)
5 okt. 2022 → 6 okt. 2022
Aktivitet: Deltagelse i arrangement eller begivenhed - typer › Deltagelse i workshop, seminar og kursus
The Importance of Social Sciences for a One Health Approach to Antimicrobial Resistance
Minssen, Timo (Andet)
18 aug. 2020
Aktivitet: Tale eller præsentation - typer › Foredrag og mundtlige bidrag
The Legal Dimensions of Quantum Computing
Minssen, Timo (Inviteret foredragsholder) & Druedahl, Louise C. (Inviteret foredragsholder)
29 apr. 2022
Aktivitet: Deltagelse i arrangement eller begivenhed - typer › Organisation af og deltagelse i konference
The Patent Governance of Genome Editing Technologies
Minssen, Timo (Andet)
9 jun. 2022
Aktivitet: Tale eller præsentation - typer › Foredrag og mundtlige bidrag
The Patent-Eligibility of Dosage Regimes and Diagnostic Methods in the U.S. & Europe
Minssen, Timo (Oplægsholder)
13 sep. 2011
Aktivitet: Tale eller præsentation - typer › Foredrag og mundtlige bidrag
The Path to Legalized Medical Assistance in Dying in Canada and the Role of Evidence
Minssen, Timo (Arrangør)
8 feb. 2018
Aktivitet: Deltagelse i arrangement eller begivenhed - typer › Organisation af og deltagelse i konference
The Proposed EU IP Exception for Generics & Biosimilars Exports - A Cure Worse Than the Disease? (at UC Irvine)
Minssen, Timo (Inviteret foredragsholder)
8 feb. 2019
Aktivitet: Tale eller præsentation - typer › Foredrag og mundtlige bidrag
The UPCA’s ”opt out” and “opt-in” provisions - Impact and strategies for European patent portfolios.
Minssen, Timo (Foredragsholder)
7 okt. 2014
Aktivitet: Tale eller præsentation - typer › Foredrag og mundtlige bidrag
The US Supreme Court in FTC v. Actavis - Context, outcome & implications
Minssen, Timo (Foredragsholder)
18 jun. 2013
Aktivitet: Tale eller præsentation - typer › Foredrag og mundtlige bidrag

Forrige 1...33 34 35 36 37 38 39 40 ...42 Næste

ID: 16150437

Det Juridiske Fakultet

Timo Minssen

JUR Center for Advanced Studies in Bioscience Innovation Law

The Future Of AMR Policy Expert Workshop

The INAMRSS/CeBIL Copenhagen AMR Workshop: Solutions to AMR from the Social Sciences

The Importance of Social Sciences for a One Health Approach to Antimicrobial Resistance

The Legal Dimensions of Quantum Computing

The Patent Governance of Genome Editing Technologies

The Patent-Eligibility of Dosage Regimes and Diagnostic Methods in the U.S. & Europe

The Path to Legalized Medical Assistance in Dying in Canada and the Role of Evidence

The Proposed EU IP Exception for Generics & Biosimilars Exports - A Cure Worse Than the Disease? (at UC Irvine)

The UPCA’s ”opt out” and “opt-in” provisions - Impact and strategies for European patent portfolios.

The US Supreme Court in FTC v. Actavis - Context, outcome & implications

Flest downloads

När anses en bioteknologisk uppfinning vara komplett och praktiskt användbar? – Del 1: – Om nyare utvecklingar kring kravet på ’industrial application’ och ’utility’ för gen- och proteinrelaterade uppfinningar i USA och Europa

The Evolution of the CJEU’s Case Law on Stem Cell Patents: Context, Outcome and Implications of Case C‑364/13 International Stem Cell Corporation.

När anses en bioteknologisk uppfinning vara komplett och praktiskt användbar? – Del 2: Om nyare utvecklingar kring kravet på ’industrial application’ och ’utility’ för gen- och proteinrelaterade uppfinningar i USA och Europa